Products List

Walvax has successfully developed 8 licensed vaccines, including 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) and Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine (HPV2).

In August 2024, HPV2 was successfully pre-qualified by WHO. This certification indicates that the vaccine's safety, efficacy, and quality control meet WHO standards and that the production management system of our facility complies with WHO Good Manufacturing Practices (GMP) requirements.

Quick Links

Pipeline

All Products Pneumococcal Vaccine Series Meningococcal Vaccine Series Other Vaccines

Group ACYW135 Meningococcal Polysaccharide Vaccine

Package Insert

Prevention of invasive meningococcal diseases caused by Neisseria meningitidis serogroups A, C, Y and W135 for use in individuals aged ≥ 2 years.

Group A and C Meningococcal Polysaccharide Vaccine

Package Insert

Prevention of epidemic cerebrospinal meningitis caused by Neisseria meningitidis serogroups A and C for use in individuals aged ≥ 2 years.

Group A and Group C Meningococcal Conjugate Vaccine

Package Insert

Prevention of invasive meningococcal diseases caused by Neisseria meningitidis serogroups A and C for use in infants and children 3 months through 5 years of age.